Search clinical trials for: Imiquimod (5%)

Total 7837 results

Taro Pharmaceuticals USA

Completed

Bioequivalence Study of Two Imiquimod Cream 5%

Actinic Keratosis

United States
Apotex Inc.

Completed

A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled Therapeutic Equivalence Study of Three Imiquimod Cream 5% Treatments for Patients With Actinic Keratosis

Actinic Keratosis
Graceway Pharmaceuticals, LLC

Completed

Open-label Study to Evaluate Clearance of Superficial Basal Cell Carcinoma After Use of Imiquimod 5% Cream

Superficial Basal Cell Carcinoma

Australia, New Zealand
St. Justine's Hospital
Graceway Pharmaceuticals, LLC

Completed

A Phase II Study of Imiquimod 5 % Cream for the Treatment of Hemangioma in Infancy

Hemangioma, Capillary

Canada
Graceway Pharmaceuticals, LLC

Completed

Open-Label Safety Study to Evaluate Imiquimod Cream, 5% for Large Areas of Actinic Keratosis

Keratosis

United States
Graceway Pharmaceuticals, LLC

Completed

Cellular and Molecular Events During Treatment of Actinic Keratosis With Imiquimod 5% Cream

Actinic Keratosis

United States
MEDA Pharma GmbH & Co. KG
ORION Sante

Completed

Imiquimod 5% Cream in the Treatment of External Genital or Perianal Warts in HIV+ Patients

Warts

Belgium, France
Massachusetts General Hospital

Completed

Topical Imiquimod 5% Cream for Treatment of Cutaneous Neurofibromas in Adults With Neurofibromatosis 1

Neurofibromatosis Type 1 | Cutaneous Neurofibromas

United States
The Hospital for Sick Children

Completed

Imiquimod in Children With Plaque Morphea

Scleroderma, Localized

Canada
Graceway Pharmaceuticals, LLC

Completed

1-Year Follow up to the 1473-IMIQ Study

Keratosis

United States
MEDA Pharma GmbH & Co. KG

Completed

A Study to Evaluate the Effectiveness and Safety of Multiple Applications of Imiquimod 5% Cream for the Treatment of Actinic Keratoses in Organ Transplant Recipients

Actinic Keratosis
University of Alberta
3M

Withdrawn

Imiquimod 5% Cream in Plaque-type Morphea: A Pilot, Prospective Open-label Study

Morphea

Canada
Graceway Pharmaceuticals, LLC

Completed

A Study to Evaluate the Effectiveness of Imiquimod 5% Cream for Basal Cell Carcinoma Recurrence

Basal Cell Carcinoma

United States
University of Pennsylvania

Terminated

Imiquimod for Preventing Keloid Recurrence

Keloid

United States
Graceway Pharmaceuticals, LLC

Completed

Study to Assess the Safety and Efficacy of Imiquimod 5% Cream for the Treatment of Actinic Keratosis on the Arms and Hands

Keratosis

United States
University of Sao Paulo

Unknown

Imiquimod 5% Cream for the Treatment of Periocular Basal Cell Carcinoma (Imiquimod)

Carcinoma, Basal Cell

Brazil
Rigel Dermatology

Completed

Topical Imiquimod Cream in Combination With Cryotherapy for the Treatment of Actinic Keratoses

Actinic Keratoses

United States
Barretos Cancer Hospital
Farmoquimica S.A.

Completed

Randomized Clinical Trial Evaluating the Efficacy of Topical Imiquimod in High Grade Cervical Intraepithelial Lesions

Cervix Cancer | High Grade Intraepithelial Neoplasia

Brazil
University of Chicago

Withdrawn

Photodynamic Therapy Mediated by Topical Application of 5- ALA for the Treatment of Actinic Keratoses

Actinic Keratosis

United States
Norwegian University of Science and Technology
St. Olavs Hospital

Completed

Treatment Study for Actinic Cheilitis Comparing Imiquimod 5% and Photodynamic Therapy

Actinic Cheilitis

Norway
Centro de Investigaciones Medicas y Ensayos Clinicos...
CALOX Laboratories; Bioanalisis

Unknown

Betaglucin 0.2% Versus Imiquimod 5% in Treatment of Ano-genital Warts: Combined Results From Triple Blind Controlled Study (BETAGENWART)

Genital Wart Virus Infection

Nicaragua
Medical University Innsbruck

Not yet recruiting

Adjuvant Anal Imiquimod Therapy in Anal HPV-lesions: AdAM-trial (AdAM)

Anogenital Human Papillomavirus Infection | Condyloma Anal

Austria
Inovio Pharmaceuticals

Completed

Evaluation of VGX-3100 and Electroporation Alone or in Combination With Imiquimod for the Treatment of HPV-16 and/or HPV-18 Related Vulvar HSIL (Also Referred as: VIN 2 or VIN 3)

Human Papillomavirus (HPV) | Vulvar Dysplasia | Vulvar Intraepithelial Neoplasia (VIN) | Vulvar High Grade Squamous Intraepithelial Lesion (HSIL) | VIN2 | VIN3 | Pre-cancerous Lesions of the Vulva

United States
University of Miami
Graceway Pharmaceuticals, LLC

Completed

Topical Imiquimod in Conjunction With Nd:YAG Laser for Tattoo Removal

Healthy

United States
Medical University of Vienna

Terminated

Imiquimod Versus Photodynamic Therapy of Actinic Keratoses in Organ Transplant Recipients (AKtransplant)

Actinic Keratoses

Austria
VA Office of Research and Development

Not yet recruiting

Basal Cell Carcinoma Chemoprevention Trial (B3C)

Basal Cell Carcinoma

United States
University of California, Irvine
Beckman Laser Institute University of California Irvine

Completed

Combining Topical Imiquimod 5% Cream With a Pulsed Dye Laser to Treat Port Wine Stain Birthmarks (Aldara)

Port Wine Stain

United States
LEO Pharma

Completed

Risk of Squamous Cell Carcinoma on Skin Areas Treated With Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5%

Actinic Keratosis (AK)

Germany, United Kingdom, France
AIDS Malignancy Consortium
National Cancer Institute (NCI); University of Arkansas; The Emmes Company, LLC

Active, not recruiting

Imiquimod, Fluorouracil, or Observation in Treating HIV-Positive Patients With High-Grade Anal Squamous Skin Lesions

HIV Infection | Anal Intraepithelial Neoplasia | High-grade Squamous Intraepithelial Lesion

United States, Puerto Rico
Hospital de Clinicas de Porto Alegre
Federal University of Rio Grande do Sul

Terminated

Topical Application of Imiquimod Gel at Different Concentrations in Actinic Cheilitis

Actinic Cheilitis

Brazil
University Medical Centre Maribor

Active, not recruiting

Comparison of Treatment of Cervical Intraepithelial Lesions With Imiquimod or LLETZ

Intraepithelial Neoplasia, Cervical

Slovenia
Maastricht University Medical Center

Active, not recruiting

Surgery Versus Combined Treatment With Curettage and Imiquimod for Nodular Basal Cell Carcinoma (SCIN)

Nodular Basal Cell Carcinoma

Netherlands
Xiangya Hospital of Central South University

Unknown

A Personalized NeoAntigen Cancer Vaccine Combined With Anti-PD-1 in Melanoma

Melanoma (Skin)

China
Graceway Pharmaceuticals, LLC

Completed

Phase 3 Study of Imiquimod Creams in the Treatment of External Genital Warts

Genital Warts

United States
Graceway Pharmaceuticals, LLC

Completed

Safety and Effectiveness Study of Imiquimod Creams in the Treatment of External Genital Warts

Genital Warts

United States
Medical University of South Carolina

Active, not recruiting

Topical Aldara (Imiquimod) for Oral Cancer

Oral Cancer

United States
Melissa Pugliano-Mauro
National Cancer Institute (NCI)

Recruiting

Intralesional 5-Fluorouracil (5FU), Topical Imiquimod Treatment for SCC

Carcinoma, Squamous Cell

United States
The University of Hong Kong

Completed

ID HBV Vaccination With Imiquimod in OBI

Hepatitis B

Hong Kong
Jerry Marsden
Department of Health, United Kingdom

Completed

Effect of Topical Imiquimod on Lentigo Maligna (LIMIT-1)

Lentigo Maligna

United Kingdom
Hordinsky, Maria K., MD
National Alopecia Areata Foundation

Completed

Characteristics of T Cells From Alopecia Areata Scalp Skin Before and After Treatment With Aldara 5%

Alopecia Areata

United States
AIDS Malignancy Consortium
National Cancer Institute (NCI); University of California, San Francisco; University... and other collaborators

Active, not recruiting

Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Lesions (ANCHOR)

HIV Infection | Anal Cancer | Human Papilloma Virus Infection | High-grade Squamous Intraepithelial Lesion

United States, Puerto Rico
Teva Pharmaceuticals USA

Completed

Study Comparing Imiquimod Cream, 3.75% to Zyclara® (Imiquimod) Cream, 3.75% in the Treatment of Actinic Keratosis

Actinic Keratosis

United States
Taro Pharmaceuticals USA

Completed

Clinical Study to Evaluate the Bioequivalence of Two Imiquimod Cream 3.75% Formulations in Patients With Actinic Keratosis.

Actinic Keratosis
Hordinsky, Maria K., MD
3M; National Alopecia Areata Foundation

Completed

Aldara for the Treatment of Extensive Alopecia Areata

Alopecia Areata

United States
Maruho Co., Ltd.

Completed

Topical Challenge With Omiganan and Imiquimod in Healthy Volunteers

Healthy

Netherlands
MEDA Pharma GmbH & Co. KG

Completed

A Study to Evaluate Effectiveness of Imiquimod 5% Cream in Superficial Basal Cell Carcinoma

Basal Cell Carcinoma

Germany
University of British Columbia
Vancouver Coastal Health Research Institute; 3M

Completed

Safety and Efficacy of Imiquimod Applied in Dose-Cycle for Actinic Keratoses

Actinic Keratoses

Canada
Wake Forest University

Completed

Treatment of Nodular Basal Cell Carcinoma (BCC) With Imiquimod 5% Cream After Curettage

Basal Cell Carcinoma

United States
Graceway Pharmaceuticals, LLC

Completed

Safety and Effectiveness Study of Imiquimod Creams for Treatment of Actinic Keratoses (AKs)

Actinic Keratoses

United States
Icahn School of Medicine at Mount Sinai
Bausch Health Americas, Inc.

Completed

Genomic Markers Before and After Treatment of Actinic Keratosis With Imiquimod 3.75% Cream

Actinic Keratosis

United States

Search clinical trials for: Imiquimod (5%)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Denmark

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations